PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
29.95%
Revenue growth above 1.5x META's 12.29%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
16.74%
Gross profit growth 1.25-1.5x META's 12.33%. Bruce Berkowitz would see if strategic sourcing or brand premium explains outperformance.
28.36%
EBIT growth above 1.5x META's 10.27%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
28.36%
Operating income growth above 1.5x META's 16.44%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
35.00%
Net income growth above 1.5x META's 10.17%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
36.84%
EPS growth above 1.5x META's 10.47%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
36.84%
Diluted EPS growth above 1.5x META's 11.04%. David Dodd would see if there's a robust moat protecting these shareholder gains.
1.74%
Slight or no buybacks while META is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
1.74%
Slight or no buyback while META is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
-34.85%
Negative OCF growth while META is at 6.39%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-60.27%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
144.85%
10Y revenue/share CAGR under 50% of META's 1223.16%. Michael Burry would suspect a lasting competitive disadvantage.
144.85%
5Y revenue/share CAGR at 75-90% of META's 190.49%. Bill Ackman would encourage strategies to match competitor’s pace.
144.85%
3Y revenue/share CAGR above 1.5x META's 77.04%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-46.06%
Negative 10Y net income/share CAGR while META is at 2770.56%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-46.06%
Negative 5Y net income/share CAGR while META is 304.58%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-46.06%
Negative 3Y CAGR while META is 194.47%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
10.39%
R&D growth drastically higher vs. META's 6.52%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
12.99%
SG&A growth well above META's 12.01%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.